Switch to
More onapp

How to use scorecard? Learn more

Onyx Biotec Ltd

ONYX
Health CarePharmaceuticals
SmallcapWith a market cap of ₹97 cr, stock is ranked 3,087
High RiskStock is 3.20x as volatile as Nifty
64.6510.75 (+19.94%)

Price Chart

High
Low
Returns
1D
1W
1M
1Y
5Y
Max
SIP
Loading...
1D
1W
1M
1Y
5Y
Max
SIP
Scorecard

Performance

Low

Hasn't fared well - amongst the low performers

Valuation

High

Seems to be overvalued vs the market average

Growth

Low

Lagging behind the market in financials growth

Profitability

High

Showing good signs of profitability & efficiency

Entry point

Avg

The stock is not in the overbought zone

Red flags

Low

No red flag found

How to use scorecard? Learn more

Health CarePharmaceuticals
SmallcapWith a market cap of ₹97 cr, stock is ranked 3,087
High RiskStock is 3.20x as volatile as Nifty

Key MetricsEdit

No LabelNo Label
PB RatioPB Ratio
3.93
Dividend YieldDiv. Yield
Sector PESector PE
51.23
Sector PBSector PB
6.64
Sector Div YldSctr Div Yld
0.52%

Forecast & RatingsDetailed Forecast 

Forecast data is currently unavailable for this stock

Price

Price Upside

Earnings

Earnings Growth

Revenue

Rev. Growth

See Detailed Forecast

Company Profile

Onyx Biotec Ltd. is a pharmaceutical company focused on the manufacture, sale, and distribution of generic and proprietary pharmaceutical products, including sterile water for injection and various dry powder injections and syrups.

Financial TrendFinancial statements 

20222023202439.6139.6153.881.851.853.04
Revenue
Profit
All values in ₹ cr.
See financial statements

Holdings TrendDetailed holdings 

Low Pledged Promoter Holding
Lower pledged promoter holdings is considered better

Pledged promoter holdings is insignificant

See detailed holdings

Recent NewsAll news 

Hmm, looks like data is unavailable here. Please come back after some time
See all news

Recent EventsAll events 

Hmm, looks like data is unavailable here. Please come back after some time
See all events